Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
An open-label randomized Phase II study in order to explore two different sequential anthracycline-based neoadjuvant treatment regimens in female patients with primary, operable breast cancer (T2-T4/N0-2/M0).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Prior anthracyclines as part of prior anticancer therapy.
Concurrent antitumor therapy.
Second primary malignancy.
Serious concomitant systemic disorder.
Pre-existing sensorial or motor neuropathy
Primary purpose
Allocation
Interventional model
Masking
257 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal